Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Delivery Mode among Patients with Oligohydramnios with or without Fetal Growth Restriction by Induction Method.
Parasitic Microcalcifications of the Breast.
Burnout, Drop Out, Suicide: Physician Loss in Emergency Medicine, Part I.
Basic Science and Pathogenesis.
Clinical potential of SLAMF7 antibodies - focus on elotuzumab in multiple myeloma.
See All 20 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical potential of SLAMF7 antibodies - focus on elotuzumab in multiple myeloma.
Friend R, Bhutani M, Voorhees PM, Usmani SZ. Clinical potential of SLAMF7 antibodies - focus on elotuzumab in multiple myeloma. Drug Des Devel Ther. 2017; 11:893-900.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Humans
Multiple Myeloma
Signaling Lymphocytic Activation Molecule Family
authors with profiles
Saad Usmani MD